Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.

Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.

Item
http://www.wikidata.org/entity/Q36659779
A predictive data-driven framework for endocrine prioritization: a triazole fungicide case studyScientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment.Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.Guidance for the classification of carcinogens under the Globally Harmonised System of Classification and Labelling of Chemicals (GHS).New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis.Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action.Scientific Opinion on the identification of pesticides to be included in cumulative assessment groups on the basis of their toxicological profileGuidance on the assessment of the biological relevance of data in scientific assessments
P2860

Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.

Item
http://www.wikidata.org/entity/Q36659779
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@ast
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@en
type
label
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@ast
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@en
prefLabel
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@ast
Thiazopyr and thyroid disrupti ...... is of a cancer mode of action.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Thiazopyr and thyroid disrupti ...... sis of a cancer mode of action
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698